Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.

@article{Ahn2018IloprostAP,
  title={Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.},
  author={J. Ahn and K. Lee and Y. S. Choi and Jung-Hye Choi},
  journal={Prostaglandins & other lipid mediators},
  year={2018},
  volume={134},
  pages={
          47-56
        }
}
  • J. Ahn, K. Lee, +1 author Jung-Hye Choi
  • Published 2018
  • Chemistry, Medicine
  • Prostaglandins & other lipid mediators
    • Recent studies have shown that a bioactive lipid prostacyclin (PGI2) plays a role in various cancers, including lung cancer. However, the specific function of PGI2 in ovarian cancer progression has not been determined. This study investigated the effects of PGI2 on cell growth, migration, and invasion in ovarian cancer cells using iloprost, a stable PGI2 analog. Iloprost significantly inhibited migration and invasion, but not cell growth, in a dose-dependent manner in human ovarian cancer cells… CONTINUE READING
    View on PubMed
    doi.org
    11 Citations
    Background Citations
    3
    11 Citations
    Citation Type

    Citation Type

    CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
    • PDF
    Prostacyclin Analog Promotes Human Dental Pulp Cell Migration via a Matrix Metalloproteinase 9-related Pathway.
    • 3
    The Role of Eicosanoids in Gynecological Malignancies
    • 1
    • PDF
    Circular RNA ITCH suppresses proliferation, invasion, and glycolysis of ovarian cancer cells by up-regulating CDH1 via sponging miR-106a
    • 1
    The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas.
    • 3
    International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions
    • PDF
    Functional study of 14-3-3 protein epsilon (YWHAE) in keratinocytes: microarray integrating bioinformatics approaches
    • 2
    The endothelial barrier and cancer metastasis: Does the protective facet of platelet function matter?
    • 3
    Bioactive lipids, inflammation and chronic diseases.
    • 4
    Platelets in aging and cancer—“double-edged sword”
    • 2
    • PDF

    References

    SHOWING 1-10 OF 54 REFERENCES
    Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.
    • 39
    • PDF
    COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion.
    • 37
    • PDF
    Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-δ Signaling in Epithelial Ovarian Cancer
    • 35
    • PDF
    Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells.
    • 38
    • PDF
    The role of prostacyclin in lung cancer.
    • 13
    Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator–Activated Receptor γ
    • 68
    • PDF
    Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis
    • 40
    Genetic and Epigenetic Regulation of the Human Prostacyclin Synthase Promoter in Lung Cancer Cell Lines
    • 28
    • PDF
    Prostaglandin I2 analogue, iloprost, down regulates mitogen-activated protein kinases of macrophages.
    • 16
    Thromboxane A2 Regulation of Endothelial Cell Migration, Angiogenesis, and Tumor Metastasis☆
    • 157